Endoscopic block of the sphenopalatine ganglion with botulinum toxin in intractable cluster headache. Safety issues.

Trial Profile

Endoscopic block of the sphenopalatine ganglion with botulinum toxin in intractable cluster headache. Safety issues.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Mar 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Cluster headache
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Sep 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 21 Jul 2014 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 24 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top